Coarctation of the aorta is an important, treatable cause of secondary hypertension. Its
prevalence varies from 5% to 8% of all congenital heart defects. This condition is most often …

Intravascular or intracardiac stenoses occur in many forms of congenital heart disease
(CHD). Therefore, the implantation of stents has become an accepted interventional …

OBJECTIVE To determine whether corrodible materials may be safely used as
biodegradable cardiovascular implants. DESIGN Corrodible iron stents (> 99.8% iron) were …

Stent implantation in the youngest patients with a congenital heart disease implicates
limitations concerning further vessel growth, the need of staged redilation, and later surgical …

Background: Obesity is associated with increased cardiovascular morbidity and mortality. A
direct effect of isolated obesity on cardiac function is not well established. Objective: To …

OBJECTIVES The aim of this study was to evaluate the use of endovascular stents in native
and recurrent coarctation of the aorta (CoA). BACKGROUND Stents have been used …

Background: We report a multiinstitutional study on intermediate‐term outcome of
intravascular stenting for treatment of coarctation of the aorta using integrated arch imaging …

Objectives: This study sought to evaluate the use of covered Cheatham-platinum (CP) stents
in the treatment of aortic coarctation (CoA). Background: Aortic aneurysms and stent …

Aims Since the late 1980s, endovascular stents have been used in the treatment of several
vascular lesions. In the last decades, stent implantation has been proposed as a reliable …

Objective: To compare results of dilatation of native coarctation of the aorta with and without
stent implantation. Design: Open, observational, non-randomised study. Patients: 54 …